🇪🇺 Kadcyla in European Union

Kadcyla (trastuzumab-emtansine) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Kadcyla in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Kadcyla approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Kadcyla in European Union?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.